Description

Viral plaque reduction assay results illustrate the inhibitory effect of the EAM-ESN herbal blend on viral replication, with the combination demonstrating greater plaque reduction than either component alone at equivalent concentrations.

Figure 6

Chart

Source Paper

Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by the Blend of Double-Standardized Extracts of Aronia melanocarpa (Michx.) …

Pharmaceuticals (Basel, Switzerland) (2022)

PMID: 35631445

DOI: 10.3390/ph15050619

Cite This Figure

![Figure 6: Viral plaque reduction assay results illustrate the inhibitory effect of the EAM-ESN herbal blend on viral replication, with the combination demonstrating greater plaque reduction than either component alone at equivalent concentrations.]()

> Source: Michał Ochnik et al. "Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by." *Pharmaceuticals (Basel, Switzerland)*, 2022. PMID: [35631445](https://pubmed.ncbi.nlm.nih.gov/35631445/)

<figure>
  <img src="" alt="Viral plaque reduction assay results illustrate the inhibitory effect of the EAM-ESN herbal blend on viral replication, with the combination demonstrating greater plaque reduction than either component alone at equivalent concentrations." />
  <figcaption>Figure 6. Viral plaque reduction assay results illustrate the inhibitory effect of the EAM-ESN herbal blend on viral replication, with the combination demonstrating greater plaque reduction than either component alone at equivalent concentrations.<br>  Source: Michał Ochnik et al. "Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35631445/">35631445</a></figcaption>
</figure>

Preuves associées

Elderberry pour Influenza

Note B · 5 études